The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice.

RGRN-305 - Regranion, MC2 Therap

http://www.ncbi.nlm.nih.gov/pubmed/39325762

Anne Bregnhøj; Claus Johansen; Giorgia Marino; Hakim Ben Abdallah; Line S Reinert; Manja Idorn; Søren Riis Paludan

Sep 26, 2024